Social Media

Telephone

v. (971) 407-3066 | f. (971) 407-3067

Email

info@santepdx.com

ADDRESS

210 NW 17th Avenue
Portland, OR 97209

Business Hours:

Monday 10am - 6pm
Tuesday 10am - 6pm
Wednesday 10am - 6pm
Thursday 10am 6pm
Friday 10am 6pm
Saturday 10am 6pm
Sunday 10am 4pm

0%

cdn_helper

JEUVEAU: A New Era in Anti-Aging Treatment

Are you looking for a new and effective way to reduce the appearance of wrinkles and fine lines? Look no further than JEUVEAU, the newest FDA-approved injectable treatment that’s taking the anti-aging market by storm.

JEUVEAU is a type of neuromodulator that works by relaxing the facial muscles responsible for wrinkles and fine lines. This allows the skin to appear smoother and more youthful, without the need for invasive surgery or extensive downtime.

What sets JEUVEAU apart from other neuromodulators on the market? The answer lies in its unique formulation. JEUVEAU is the first and only neurotoxin that is exclusively focused on aesthetic indications. Its formulation is specially designed to deliver consistent, long-lasting results, with a fast onset of action.

JEUVEAU is an excellent option for those looking to reduce the appearance of crow’s feet, frown lines, and other facial wrinkles. It can also be used to enhance facial features, such as lifting the eyebrows or reducing the appearance of a gummy smile.

Woman's use of Jeuveau available at SANTÉ Aesthetics & Wellness in Portland, Oregon

Over 1 million frown-line free faces treated since 2019

How does Jeuveau work

When injected, Jeuveau temporarily prevents your nerves from telling your facial muscles to flex. The result? In clinical trials, Jeuveau was shown to temporarily improve the appearance of moderate to severe frown lines.

Pricing

$14 per unit

$13 per unit for members

What are the results with Jeuveau

In clinical trials, Jeuveau was shown to temporarily improve the appearance of moderate to severe frown lines. In US studies, 68% and 70% of Jeuveau patients had a 2-grade or better physician- and patient-rated improvement in frown lines at Day 30. But that’s not all. In a study conducted in Europe and Canada, 54% of patients had visible results as early as 2 days after treatment.* And at 5 months after treatment, 38% of patients had visible results with Jeuveau**

SCHEDULE APPOINTMENT
jeuveau as soon in the magazines of NewBeauty, Allure, Refinery29, Bloomberg, and BOF

Before and After Photos

About SANTÉ Aesthetics & Wellness

At SANTÉ, our experienced medical professionals are highly trained in the use of JEUVEAU and other injectable treatments. We will work closely with you to create a personalized treatment plan that achieves your desired results while ensuring your comfort and safety throughout the process.

If you’re ready to experience the transformative effects of JEUVEAU for yourself, schedule a consultation with us today. Let us help you achieve a more youthful, refreshed appearance that will have you feeling confident and beautiful.

CONTACT US TO SCHEDULE AN APPOINTMENT OR CONSULTATION

Click the button below to schedule an appointment online. You can also call us at (971) 407-3066 and our front desk will happily book your appointment with our fantastic staff.

We are conveniently located in the Northwest District of Portland in the Historic 210 Building. Convenient to Lake Oswego, Beaverton, Tigard, Hillsboro, Milwaukee, and Vancouver, Washington.

Jeuveau available at SANTÉ Aesthetics & Wellness in Portland, Oregon
SCHEDULE APPOINTMENT

*54% of Jeuveau patients had a ≥1-grade improvement in frown lines at Day 2 based on physician assessment compared to 12% for placebo (secondary endpoint). In US studies, 46% and 56% had a ≥1-grade improvement in frown lines at Day 2 based on physician assessment compared to 8% and 17% for placebo (exploratory endpoint). Results based on a 1-grade improvement may not be clinically meaningful.

*38% of Jeuveau patients had a ≥1-grade improvement in frown lines at 5 months based on physician assessment compared to 8% for placebo (secondary endpoint). In US studies, almost 5% of patients had a ≥2-grade improvement in frown lines at 5 months based on both patient and physician assessments compared to 0% for placebo (secondary endpoint). Results after day 30 or based on a 1-grade improvement may not be clinically meaningful.

╳